We are developing digital health care solutions to improve provider and patient outcomes through technology and education that build trust into doctor-patient relationships for today and tomorrow.
On the Verge of Change
Dentistry is challenging for both the patient AND the doctor! Our ChairSide Solutions help solve problems. Shorter visits. Less discomfort. Lowering the cost of care.
We now know, germs in the gum line can contribute to shorter diminished quality and quantity of life! Now, more than ever, we can help.
How the plaque on your teeth may be connected to plaque in your arteries
Several cohort studies have shown that periodontal disease is associated with an increased risk of stroke [2–5]. A recent meta-analysis of 2 cohort studies found that periodontal disease increased the risk of ischemic stroke by 1.6-fold . Gum disease may increase your risk of colorectal cancer.
A new study, published in Cancer Prevention Research, included 42,486 men and women participating in two large continuing health surveys. Over the past several decades, the participants had periodically reported information on health and diet, including reports of gingivitis and tooth loss.
It has now been established that oral pathogens, inhabiting in deep pockets of the gum line, are responsible for:
Dr. Jeffrey M. Rosenberg
Founder & Chief Science Officer
40 Years of Experience
Welcome to the new frontier
Changing the Oral Health Market
Quanotech was started on the premise that there had to be a better way to take findings from a periodontal records visit and systematize, streamline, and increase the accuracy of the findings. The founder, Dr. Jeffrey M. Rosenberg, had adopted early research of Dr. Paul Keyes, of the then (1976-77) National Institute for Dental Research (NIDR) which led to many current principals for oral health – namely the baking soda and peroxide method of oral “disinfection”, and the concept that findings of the periodontal examination related to distant systemic diseases. Periodontal disease is the leading cause of tooth loss. PerioAlert™ is an early detection digital chairside scanner. This time in the 1970’s was the emergence of what is now Oral-Systemic Health (OSH). On February 9, 2004, Quanotech LLC was formed in the state of Pennsylvania.
Looking Towards the Future
The New Oral Health Market
A recent in-depth study reveals a strong and growing market for oral health-care products and services. The world oral care market in 2020 was valued at $53 billion in US dollars and it is estimated that the market will be valued at $96 billion by the end of 2031.
The global market for Alzheimer’s Disease (AD) treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion by 2023, representing a Compound Annual Growth Rate (CAGR) of 10.50%, according to research and consulting firm GlobalData.
Quanotech is poised to be a leader in the new emerging Oral Health market.
Scan, Design, and Print
A subscription service for ChairSide Solutions to shorter, more comfortable, and profitable office dental visits.
Diseases of the Gum Line
When the studies of Oral-Systemic health (OSH) determined that gum disease-causing bacteria found in the gum line were related to diabetes, Alzheimer’s Disease (AD), Cardiovascular Disease (CVD), and stroke, PerioAlert became an essential component of diagnosing periodontal disease (PD).
About 700 kinds of microorganisms exist in the human mouth, and these microbes constitute the human oral microbiota. It is one of the most complex microbial communities in the human body.
There is evidence that oral microbiota is also closely related to systemic diseases including rheumatoid arthritis (RA), adverse pregnancy outcomes, stroke, and cardiovascular disease.
Periodontal disease is the leading cause of tooth loss. PerioAlert is an early detection digital chair-side scanner.
Proprietary Research Protected
The Digital Oral Cavity
A subscription service for chair-side solutions to shorter, more comfortable, and profitable office dental visits.
Plan: treatment from simple crown and bridge case, to complex smile design and rapid chairside print provisionals.
Headaches: Simplified jaw and headache reduction devices.
Sleep Apnea: Design and print custom oral sleep apnea appliances and titrate for optimal airway improvement, and re-print.
Be a part of the future Oral Health
Quanotech is in Series A & B funding, We are ramping up our proprietary software subscription, Scan, Design, Print.
We will be taking offers for the subscription in late 2022.
Series A Funding:
- Targeting $5.0 Million
- Poised to be a leader in the new emerging Oral Health market
- First-round funding for design development, verification, and validation
- Initial regulatory & reimbursement strategy